Moderna is Developing its First African Vaccine Plant in Kenya Worth $500M
Moderna, a biotechnology and pharmaceuticals company based in Massachusetts, is planning to build a manufacturing facility in Kenya to produce mRNA vaccines, including those for COVID-19. The facility will be Moderna’s first manufacturing plant in Africa, with the company investing $500 million in its construction in order to supply up to 500 million doses of…